Global science innovation is rapidly shifting to Asia as investment, talent, and R&D infrastructure surge, challenging Western dominance and reshaping pharmaceutical competition worldwide.
Asia Society’s new report probes the changing landscape of U.S.-China relations in the life sciences, where competition and collaboration increasingly intertwine. It highlights policy flashpoints, deep research linkages, and the …